Wednesday, 11 May 2022

Sun Pharma Halol unit gets 10 observations under USFDA Form 483

Sun Pharma Halol unit gets 10 observations under USFDA Form 483
Sun Pharma Halol unit gets 10 observations under USFDA Form 483

US FDA has conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Limited Halol facility Gujarat from April 26 to May 9, 2022. At the conclusion of the inspection, the US FDA issued a Form-483, with 10 observations.

admin Wed, 05/11/2022 - 15:42

source https://www.pharmatutor.org/pharma-news/2022/sun-pharma-halol-unit-gets-10-observations-under-usfda-form-483

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...